跳转至内容
Merck
CN

HPLC Analysis of Insulin Variants and Analogs on BIOshell A160 Peptide CN

HPLC Analysis of Insulin Variants and Analogs on BIOshell A160 Peptide CN application for HPLC

材料

相关产品

产品编号
说明
价格

BIOshell A160 Peptide CN, 2.7 μm HPLC Column

2.7 μm particle size, L × I.D. 15 cm × 2.1 mm

CONDITIONS

column

BIOshell A160 Peptide CN, 15 cm x 2.1 mm, 2.7 μm particles (66969-U)

mobile phase

[A] 75:25 water (0.1% trifluoroacetic acid): acetonitrile (0.1% trifluoroacetic acid); [B] 50:50 water (0.1% trifluoroacetic acid): acetonitrile (0.1% trifluoroacetic acid); (87:13, A:B)

flow rate

0.5 mL/min

pressure

3200 psi (220 bar)

column temp.

75 °C

detector

UV, 215 nm

injection

0.5 μL

sample

Mixture of six insulin variants, 100 μg/mL in 0.1% aqueous trifluoroacetic acid

说明

分析说明

The BIOshell A160 Peptide CN, with cyanopropyl functional groups, can provide alternative selectivity to a traditional C18 phase. Selectivity using the CN phase is primarily due to hydrophobicity and dipole-dipole interactions. A mixture of six insulin variants was separated using the BIOshell A160 Peptide CN column. Alternative selectivity of the first two analytes is seen using this column compared to the BIOshell A160 Peptide C18.

法律信息

null